永耀集團控股(08022.HK)擬折讓約7.14%增發3.61億股 淨籌932萬港元
格隆匯1月3日丨永耀集團控股(08022.HK)公告,於2020年1月3日,公司與認購方訂立認購協議,據此,認購方已有條件同意認購,而公司已有條件同意以認購價每股認購股份0.026港元配發及發行合共3.61億股認購股份。認購價0.026港元相當於2020年1月3日公司收市價每股股份0.028港元折讓約7.14%。
認購股份相當經擴大已發行股份約16.67%(假設於本公佈日期至完成期間已發行股份總數概無變動(發行認購股份除外))。發行認購股份所得款項總額及所得款項淨額估計將分別約為938萬港元及932萬港元。公司擬將所得款項淨額用於償還未償還債務及作為集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.